Unitedhealth Group Inc (UNH) concluded trading on Thursday at a closing price of $529.77, with 4.58 million shares of worth about $2.42 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -4.49% during that period and on January 23, 2025 the price saw a gain of about 1.93%. Currently the company’s common shares owned by public are about 920.28M shares, out of which, 918.17M shares are available for trading.
Stock saw a price change of -2.51% in past 5 days and over the past one month there was a price change of 8.28%. Year-to-date (YTD), UNH shares are showing a performance of 4.73% which increased to 3.27% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $436.38 but also hit the highest price of $630.73 during that period. The average intraday trading volume for Unitedhealth Group Inc shares is 4.82 million. The stock is currently trading 2.26% above its 20-day simple moving average (SMA20), while that difference is down -3.74% for SMA50 and it goes to -2.29% lower than SMA200.
Unitedhealth Group Inc (NYSE: UNH) currently have 920.28M outstanding shares and institutions hold larger chunk of about 89.53% of that.
The stock has a current market capitalization of $487.54B and its 3Y-monthly beta is at 0.62. PE ratio of stock for trailing 12 months is 34.09, while it has posted earnings per share of $15.54 in the same period. Its PEG reads 2.62 while making debt-to-equity ratio of 0.81. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for UNH, volatility over the week remained 3.20% while standing at 2.29% over the month.
Analysts are in expectations that Unitedhealth Group Inc (UNH) stock would likely to be making an EPS of 7.32 in the current quarter, while forecast for next quarter EPS is 7.51 and it is 33.52 for next year. For the current quarter EPS, analysts have given the company a lowest target 5.89 which is 7.91 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of 6.91 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 7.45% while it is estimated to increase by 12.62% in next year. EPS is likely to grow at an annualized rate of 13.00% for next 5-years, compared to annual growth of 1.60% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by HSBC Securities on January 10, 2025 offering a Buy rating for the stock and assigned a target price of $595 to it. Coverage by Truist stated Unitedhealth Group Inc (UNH) stock as a Buy in their note to investors on January 06, 2025, suggesting a price target of $610 for the stock. On October 17, 2024, HSBC Securities Downgrade their recommendations, while on October 11, 2024, KeyBanc Capital Markets Initiated their ratings for the stock with a price target of $675. Stock get a Buy rating from Jefferies on July 17, 2024.
